01Ask whether the result describes movement or guidance

Boneschansker and colleagues’ original leukocyte-migration platform measured the responding fraction, directionality, speed and persistence. It showed why these features can describe different aspects of a population’s response to a chemical gradient.Boneschansker and colleagues — Microfluidic platform for the quantitative analysis of leukocyte migration signatures (opens in a new tab)

Chemokinesis describes a chemically associated change in movement without requiring a directional bias towards the cue. Chemotaxis requires the directional relationship to be part of the evidence.

Read whether the study tracked individual cells or counted cells reaching a destination. The latter can quantify an endpoint but does not reconstruct the paths taken to reach it.

For a mixed immune-cell preparation, identify which cells contributed to the measured response. An aggregate count should not automatically be assigned to every cell type in the mixture.

The same distinction applies to a claimed inhibitory effect. Fewer arrivals do not by themselves show whether the intervention affected guidance, movement, cell availability or another part of the assay.

02Read speed and directional displacement separately

A and B travel the same total distance, but A makes much more progress towards the cue. C travels less distance while showing the same ratio of directional progress to path length as A.

These invented paths demonstrate why speed alone cannot represent directional efficiency. They also show why a directional ratio alone does not describe how far or how quickly a cell moved.

Read the paper’s definition of directionality rather than assume all studies use the same metric. Some summaries concern displacement relative to a gradient; others concern path straightness or angular distributions.

Population averages also need context. Oppositely directed subgroups can produce a small mean displacement even when many individual cells move substantially. Individual paths or subgroup summaries can help resolve that situation.

03Identify the cue the cells actually encountered

Schwarz and colleagues’ original microfluidic study examined dendritic-cell responses to both surface-bound and soluble chemokine gradients. It distinguishes how a guidance molecule is presented from merely recording its name in the medium.Schwarz and colleagues — A microfluidic device for measuring cell migration towards substrate-bound and soluble chemokine gradients (opens in a new tab)

For any gradient experiment, identify the direction, spatial arrangement and observation window over which the cue was characterised. The starting addition to a reservoir does not by itself describe every later exposure experienced by a moving cell.

Read whether the reported gradient belongs to the tested molecule or to a tracer used to characterise the device. The latter is evidence about the model, with the relationship to the actual cue needing explanation.

Where several cues are present, preserve that combination. A response in a competing-gradient experiment addresses a different question from a response to one isolated cue.

04Connect the measured path with the proposed immune effect

Directed movement in a laboratory system is evidence about migration under those conditions. It does not automatically establish recruitment to a tissue or the immune consequences of that recruitment.

A tissue-level claim requires observations at the relevant level, including which cells reached which location. A claim about activation or immune function needs its own functional evidence.

When comparing papers, align the immune-cell population, cue presentation and path metric before interpreting differences as a disagreement about the peptide itself.

A useful summary identifies the fraction that responded and the direction, speed or persistence that changed. It then states the gradient and model context. This preserves the migration evidence without turning every increase in movement into a general claim of improved immunity.